Standardization of prothrombin fragment 1.2 measurement: Effects of preanalytical variables and calibrator selection

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 1, 1998, Pages 31-36

  Hursting, Marcie J ^a,c   Slaughter, Thomas F ^b   Stead, Andrew G ^a   Szewczyk, Krystyna M ^a   Witt, Donald J ^a   Greenberg, Charles S ^b,d  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CITRIC ACID; DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE; EDETIC ACID; HEPARIN; PROTHROMBIN; THROMBIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; MEASUREMENT; STANDARDIZATION;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION; CALIBRATION; CATHETERS, INDWELLING; CITRATES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; PROTHROMBIN;

EID: 0031895955     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bauer K, Rosenberg R. The pathophysiology of the prethrombotic state in humans: insight gained from studies using markers of hemostatic system activa tion. Blood. 1987;70:343-350.
2. Bruhn HD, Conard J, Mannucci M, et al. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination. Thromb Haemost. 1992;68: 413-417.
3. Greenberg CS, Hursting MJ, Macik BG, Ortel TL, Kane WH, Moore BM. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem. 1994;40:1962-1969.
4. Slaughter TF, LeBleu TH, Douglas JM, Leslie JB, Parker JK, Greenberg CS. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology. 1994;80:520-526.
5. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost. 1991;65:153-159.
6. Shi Q, Sio R, Lin S, et al. Performance characteristics of an enzyme-linked immunosorbent (ELISA) assay for prothrombin fragment F1.2. Thromb Haemost. 1991;65:1118. Abstract.
7. Hursting MJ, Butman BT, Steiner JP, et al. Monoclonal antibodies specific for prothrombin fragment 1.2 and their use in a quantitative enzyme-linked immunosorbent assay. Clin Chem. 1993;39:583-591.
8. Rosenberg RD, Bauer KA. Prothrombin activation fragment assay. Clin Chem. 1993;39:559-560. Editorial.
9. Miller GJ, Bauer KA, Barzegar S, et al. The effects of quality and timing of venepuncture on markers of blood coagulation. Thromb Haemost. 1995;73:82-86.
10. Tripodi A, Chantarangkul V, Bottasso B, Mannucci PM. Poor comparability of prothrombin fragment 1+2 values measured by two commercial ELISA methods: influence of different anticoagulants and standards. Thromb Haemost. 1994; 71:605-608.
11. D'Angelo A, Valle PD, Calori G, Galli L, D'Angelo SV. Harmonization of commercial ELISA methods for the measurement of prothrombin fragment 1.2: is it feasible? Thromb Haemost. 1995;73:548. Letter.
12. Tripodi A, Chantarangkul V, Braga M, Mannucci PM. Comparison of commercial ELISA methods for the measurement of prothrombin fragment 1+2 -Rebuttal. Thromb Haemost. 1995;73:549-550. Letter.
13. Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture. 3rd ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1991.
14. Hursting MJ, Stead AG, Crout FV, Horvath BZ, Moore BM. Effects of age, race, sex and smoking on prothrombin fragment 1.2 in a healthy population. Clin Chem. 1993;39:683-686.
15. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 2nd ed. Boston, Mass: PWS-Kent Publishing; 1988: 80-95.
16. Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombin complex. Blood. 1982;5:1086-1097.
17. Bauer KA, Barzegar S, Rosenberg RD. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1+2 measurements. Thromb Res. 1991;63:617-628.
18. Rahr HB, Sorensen JV, Danielson D. Markers of coagulation and fibrinolysis in blood drawn into citrate with and without D-Phe-Pro-Arg-chloromethylke-tone (PPACK). Thromb Res. 1994;73:279-284.